Literature DB >> 27629137

Does IGF-1 play a role in the biology of endometrial cancer?

Dominika Majchrzak-Baczmańska1, Andrzej Malinowski.   

Abstract

Insulin-like growth factor 1 (IGF-1) is a mitogen which plays a key role in regulating cell proliferation, differentiation, and apoptosis. It belongs to the family of proteins also composed of insulin-like growth factor 2 (IGF-2), two types of membrane receptors (IGF-1R and IGF-2R), 6 binding proteins (IGFBP 1-6), hydrolyzing proteases, and reactive molecules binding proteins, which regulate the activity of growth factors. Disturbances in the functioning of IGFBP/IGF/1GF1R can lead to induction of carcinogenesis, which has been demonstrated in breast, prostate or colon cancers. Findings evaluating the role of IGF-1 in endometrial cancer biology are ambiguous and contradictory. Therefore, in the present study, we analyzed the role of IGF-1 in the process of carcinogenesis of endometrial cancer, based on the available literature.

Entities:  

Keywords:  carcinogenesis; endometrial cancer; insulin-like growth factor-1

Mesh:

Substances:

Year:  2016        PMID: 27629137     DOI: 10.5603/GP.2016.0052

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  6 in total

1.  Insulin signaling is an essential regulator of endometrial proliferation and implantation in mice.

Authors:  Nikola Sekulovski; Allison E Whorton; Mingxin Shi; Kanako Hayashi; James A MacLean
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.191

Review 2.  The Influence of Biologically Active Substances Secreted by the Adipose Tissue on Endometrial Cancer.

Authors:  Kaja Michalczyk; Natalia Niklas; Małgorzata Rychlicka; Aneta Cymbaluk-Płoska
Journal:  Diagnostics (Basel)       Date:  2021-03-11

3.  MLLT11-TRIL complex promotes the progression of endometrial cancer through PI3K/AKT/mTOR signaling pathway.

Authors:  Jingnan Liao; Huan Chen; Mingming Qi; Jinjin Wang; Mingyuan Wang
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.742

4.  Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets.

Authors:  Yinqi Zhang; Chengqi Gao; Fei Cao; Ying Wu; Shuanggang Chen; Xue Han; Jingqin Mo; Zhiyu Qiu; Weijun Fan; Penghui Zhou; Lujun Shen
Journal:  Front Oncol       Date:  2021-11-05       Impact factor: 6.244

Review 5.  Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review.

Authors:  Shuwen Ge; Bo Wang; Zihao Wang; Junjian He; Xiaoxin Ma
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

6.  Immunohistochemical expression of insulin-like growth factor-1Ec in primary endometrial carcinoma: Association with PTEN, p53 and survivin expression.

Authors:  Aggelis Stavropoulos; Michail Varras; Anastassios Philippou; Thivi Vasilakaki; Viktoria-Konstantina Varra; Fani-Niki Varra; Aikaterini Tsavari; Andreas C Lazaris; Michael Koutsilieris
Journal:  Oncol Lett       Date:  2020-10-29       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.